| Antigen | 17- aa peptide of Human NLGN4 (Protein accession # Q8N0W4; ref. 1); designated as NLGN41-P control/blocking peptide conjugated to KLH; epitope location ~ C-terminus, extracellular |
| Form | Affinity purified IgG |
| Product Type | Primary Antibodies |
| SpCrossreactivity | Human NLGN41-P peptide sequence is unique to human NLGN4 protein sequence with no known counterpart in mouse or rat. Antibody cross-reactivity in various species is not known. The control peptide, because of its low mol. Wt (<3 kDa), is not suitable for Western. |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |